3 Results 3.1 Demographic characteristics of the study participants A total of 855 patients with T2DM were included in the present study, of whom 636 (74.39%) received injections of liraglutide, 137 (16.02%) of polyethylene glycol loxenatide, 44 (5.15%) of semaglutide, 23 (2.69%) of exenatide, 3 (0.35%) of dulaglutide, and 12 (1.40%) of lixisenatide
Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects
The pharmacology of adrenergic decongestants
11 A 2023 meta-analysis of nine randomized trials confirmed that PRP significantly increases hair density at 3 and 6 months compared to placebo
If you miss two or more consecutive days, you may notice a temporary return of appetite and food noise
Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3